A Randomized, Double-blind, Active- and Placebo-controlled, Parallel, Multicenter, Phase II an Exploratory Clinical Trial to Evaluate the Efficacy and Safety NVP-1203 in Patients With Acute Low Back Pain
Phase of Trial: Phase II
Latest Information Update: 28 Aug 2018
At a glance
- Drugs Aceclofenac/eperisone (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Navipharm
- 20 Aug 2018 Planned End Date changed from 30 Nov 2018 to 28 Feb 2019.
- 20 Aug 2018 Planned primary completion date changed from 31 Jul 2018 to 31 Oct 2018.
- 20 Aug 2018 Status changed from not yet recruiting to recruiting.